Study of PTC844 in Participants With Active Rheumatoid Arthritis
Status:
RECRUITING
Trial end date:
2027-10-29
Target enrollment:
Participant gender:
Summary
This study is designed to assess the safety, pharmacokinetics (PK), and biomarker effects of PTC844 compared to placebo in participants with active rheumatoid arthritis (RA).